有害な生殖細胞系または体細胞相同組換え修復(HRR)遺伝子変異転移性去勢感受性前立腺癌(mCSPC)の参加者の治療のためのアビラテロン酢酸塩およびプレドニゾン対アビラテロン酢酸塩およびプレドニゾンと組み合わせたニラパリブの研究 (AMPLITUDE)
有害な生殖細胞系または体細胞相同組換え修復(HRR)遺伝子変異転移性去勢感受性の参加者の治療のためのアビラテロン酢酸塩およびプレドニゾン対アビラテロン酢酸塩およびプレドニゾンと組み合わせたニラパリブの第3相無作為化プラセボ対照二重盲検試験前立腺がん (mCSPC)
The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with deleterious germline or somatic Homologous Recombination Repair (HRR) gene-mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) provides superior efficacy in improving radiographic progression-free survival (rPFS).
調査の概要
状態
条件
研究の種類
入学 (実際)
段階
- フェーズ 3
連絡先と場所
研究場所
-
-
Alabama
-
Homewood、Alabama、アメリカ、35209
- Urology Centers Of Alabama
-
-
Arizona
-
Phoenix、Arizona、アメリカ、85054
- Mayo Clinic Arizona
-
Tucson、Arizona、アメリカ、85741
- Urological Associates of Southern Arizona, P.C.
-
-
California
-
Los Angeles、California、アメリカ、90073
- Greater Los Angeles VA Healthcare System
-
Orange、California、アメリカ、92868
- University of California Irvine Medical Center Chao Family Comprehensive Cancer Center
-
San Bernardino、California、アメリカ、92404
- San Bernardino Urological Associates
-
San Francisco、California、アメリカ、94158
- University of San Francisco California
-
-
Colorado
-
Colorado Springs、Colorado、アメリカ、80907
- Rocky Mountain Cancer Centers
-
Denver、Colorado、アメリカ、80210
- AdventHealth Medical Group Urology of Denver
-
Lakewood、Colorado、アメリカ、80228
- Colorado Clinical Research
-
-
Connecticut
-
Norwich、Connecticut、アメリカ、06360
- Eastern Connecticut Hematology & Oncology Assoc.
-
-
Florida
-
Daytona Beach、Florida、アメリカ、32114
- Advanced Urology Institute
-
Fort Lauderdale、Florida、アメリカ、33308
- Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center
-
Jacksonville、Florida、アメリカ、32256
- Cancer Specialists of North Florida
-
Jacksonville、Florida、アメリカ、32209
- University of Florida Health Jacksonville
-
-
Indiana
-
Greenwood、Indiana、アメリカ、46143
- Urology of Indiana
-
Jeffersonville、Indiana、アメリカ、47130
- First Urology
-
-
Louisiana
-
New Orleans、Louisiana、アメリカ、70121
- Ochsner Clinic Foundation
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21201
- Baltimore VA Medical Center
-
Columbia、Maryland、アメリカ、21044
- Maryland Oncology Hematology, PA
-
Towson、Maryland、アメリカ、21204
- Chesapeake Urology Associates
-
-
Michigan
-
Troy、Michigan、アメリカ、48084
- Michigan Institute of Urology
-
-
Missouri
-
Saint Joseph、Missouri、アメリカ、64507
- Mosaic Life Care
-
St Louis、Missouri、アメリカ、63109
- St. Louis VA Medical Center
-
-
Nebraska
-
Omaha、Nebraska、アメリカ、68130
- GU Research Network
-
-
New York
-
Albany、New York、アメリカ、12206
- New York Oncology Hematology
-
New York、New York、アメリカ、10065
- Memorial Sloan Kettering Cancer Center
-
New York、New York、アメリカ、10029
- Mount Sinai
-
New York、New York、アメリカ、10010
- Manhattan VAMC
-
Syracuse、New York、アメリカ、13210
- Associated Medical Professionals
-
The Bronx、New York、アメリカ、10461
- Montefiore Medical Center
-
-
North Carolina
-
Durham、North Carolina、アメリカ、27705
- Durham VAMC
-
-
Oklahoma
-
Oklahoma City、Oklahoma、アメリカ、73104
- Stephenson Cancer Center
-
-
Oregon
-
Portland、Oregon、アメリカ、97239
- VA Portland Health Care System
-
Salem、Oregon、アメリカ、97301
- Oregon Oncology Specialists
-
-
Pennsylvania
-
Lancaster、Pennsylvania、アメリカ、17604
- Keystone Urology Specialists
-
Philadelphia、Pennsylvania、アメリカ、19104
- University of Pennsylvania
-
Philadelphia、Pennsylvania、アメリカ、19104
- Philadelphia VA Medical Center
-
Pittsburgh、Pennsylvania、アメリカ、15232
- University of Pittsburgh Medical Center (UPMC)
-
-
South Carolina
-
Charleston、South Carolina、アメリカ、29401
- Ralph H. Johnson Veterans Affairs Medical Center
-
Seneca、South Carolina、アメリカ、29672
- Prisma Health
-
-
Tennessee
-
Nashville、Tennessee、アメリカ、37209
- Urology Associates
-
-
Texas
-
Austin、Texas、アメリカ、78731
- Texas Oncology-Austin
-
Denton、Texas、アメリカ、76201
- Texas Oncology - Northeast
-
Houston、Texas、アメリカ、77027
- Houston Metro Urology
-
New Braunfels、Texas、アメリカ、78130
- Texas Oncology P A
-
Tyler、Texas、アメリカ、75702
- Texas Oncology - Northeast 1
-
-
Utah
-
Salt Lake City、Utah、アメリカ、84112
- University of Utah Huntsman Cancer Institute
-
-
Virginia
-
Norfolk、Virginia、アメリカ、23502
- Virginia Oncology Associates
-
Richmond、Virginia、アメリカ、23298
- Virginia Commonwealth University - Massey Cancer Center
-
-
Washington
-
Seattle、Washington、アメリカ、98109
- Fred Hutchinson Cancer Research Center
-
Seattle、Washington、アメリカ、98108
- VA Puget Sound Healthcare System
-
Tacoma、Washington、アメリカ、98405
- MultiCare Health System
-
-
-
-
-
Buenos Aires、アルゼンチン、C1419AHN
- Asociacion de Beneficencia Hospital Sirio Libanes
-
Buenos Aires、アルゼンチン、C1426AGE
- Centro Oncológico Korben
-
Buenos Aires、アルゼンチン、C1061AAS
- CIPREC
-
C.a.b.a.、アルゼンチン、C1426BOR
- Hospital Militar Cosme Argerich
-
Caba、アルゼンチン、C1056ABI
- CINME Centro de Investigaciones Metabolicas
-
Ciudad Automoma Buenos Aires、アルゼンチン、C1120AAT
- Centro de Urologia (CDU)
-
Ciudad Autonoma de、アルゼンチン、C1199ABB
- Hospital Italiano de Buenos Aires
-
Ciudad de Buenos Aires、アルゼンチン、C1430EGF
- Clinica Adventista Belgrano
-
Córdoba、アルゼンチン、5000
- Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
-
Córdoba、アルゼンチン、X5000KPH
- Centro Urologico Profesor Bengio
-
Córdoba、アルゼンチン、X5800
- Instituto Médico de Río Cuarto
-
Córdoba、アルゼンチン、XX5016KEH
- Hospital Privado de Cordoba
-
Mar del Plata、アルゼンチン、B7602CBM
- Hospital Privado de Comunidad
-
Pergamino、アルゼンチン、B2700CPM
- Centro de Investigacion Pergamino SA
-
San Salvador de Jujuy、アルゼンチン、Y4600AFW
- ARS Médica
-
-
-
-
-
Bangor、イギリス、LL57 2PW
- Ysbyty Gwynedd
-
Belfast、イギリス、BT9 7AB
- Belfast City Hospital
-
Brighton、イギリス、BN2 5BE
- Brighton and Sussex University Hospitals NHS Trust
-
Bristol、イギリス、BS2 8ED
- Bristol Haematology and Oncology Centre
-
Great Maze Pond、イギリス、SE1 9RT
- Guy's Hospital
-
Grimsby、イギリス、DN33 2BA
- Prince Of Wales Hospital
-
Hillingdon、イギリス、HA6 2RN
- Marie Curie Research Wing - Mount Vernon Hospital
-
Inverness、イギリス、IV2 3UJ
- Raigmore Hospital
-
London、イギリス、NW1 2PG
- University College London Hospitals NHSFT
-
Oxford、イギリス、OX3 7LE
- Churchill Hospital
-
Preston、イギリス、PR2 9HT
- Royal Preston Hospital
-
Sutton、イギリス、SM2 5PT
- Royal Marsden Hospital
-
Truro、イギリス、TR1 3LJ
- Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
-
-
-
-
-
Afula、イスラエル、1834111
- Haemek Medical Center - Afula
-
Beersheba、イスラエル、85101
- Soroka Hospital
-
Haifa、イスラエル、31096
- Rambam Medical Center
-
Jerusalem、イスラエル、91200
- Hadassah Hospital
-
Petach Tikvah、イスラエル、49100
- Rabin Medical Center, Beilinson Hospital
-
Ramat Gan、イスラエル、52621
- Sheba Medical Center Tel Hashomer
-
Tel Aviv、イスラエル、64239
- Tel Aviv Sourasky Medical Center
-
-
-
-
-
Arezzo、イタリア、52100
- Ospedale S. Donato - Asl 8 Arezzo
-
Candiolo、イタリア、10060
- Divisione di Oncologia - Istituto per la ricerca e cura del cancro
-
Cremona、イタリア、26100
- Istituti Ospitalieri di Cremona, AO di Cremona
-
Lecce、イタリア、73100
- Azienda Ospedaliera ''Vito Fazzi''
-
Meldola、イタリア、47014
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
-
Milan、イタリア、20132
- Ospedale San Raffaele
-
Milan、イタリア、20133
- Fondazione IRCCS Istituto Nazionale dei Tumori
-
Milan、イタリア、20141
- European Institute of Oncology
-
Naples、イタリア、80138
- Fondazione G Pascale Istituto Nazionale Tumori IRCCS
-
Orbassano、イタリア、10043
- Aou San Luigi Gonzaga
-
Padova、イタリア、35128
- Istituto Oncologico Veneto Iov Irccs Padova
-
Pisa、イタリア、56126
- Azienda Ospedaliero Universitaria Pisana
-
Pozzuoli、イタリア、80078
- ASL Napoli 2 Nord-SM delle Grazie Hospital
-
San Giovanni Rotondo、イタリア、71013
- Casa Sollievo Della Sofferenza IRCCS
-
Trento、イタリア
- Ospedale S. Chiara
-
Vicenza、イタリア、36100
- Ospedale San Bortolo
-
-
-
-
-
Cherkasy、ウクライナ、18009
- CNE Clinical Center of Oncology Hematology Transplantology and Palliative Care of the Cherkasy RC
-
Chernivtsi、ウクライナ、58013
- Municipal Non-profit enterprise 'Bukovinian clinical oncology center'
-
Dnipro、ウクライナ、49102
- Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4
-
Dnipro、ウクライナ、49100
- Municipal Institution 'Clinical Oncology Dispensary' Under Dnipropetrovsk Regional Council
-
Dnipro、ウクライナ、49005
- Ce 'Dnipropetrovsk Regional Clinical Hospital N.A. Mechnikov' of Dnipropetrovsk Rc
-
Ivano-Frankivsk、ウクライナ、76008
- Ivano-Frankivsk Regional Clinical Hospital
-
Kamyanske、ウクライナ、51900
- Communal Institution 'City hospital №7 of Kamianske' of Dnepropetrov'sk Regional Council
-
Khakhiv、ウクライナ、61070
- Municipal non-profit enterprise 'Regional Center of Oncology'
-
Kharkiv、ウクライナ、61037
- Regional Medical Clinical Center for Urology and Nephrology named after V.I. Shapoval
-
Kherson、ウクライナ、73035
- Kherson Regional Oncological Dispensary
-
Kyiv、ウクライナ、04107
- Kyiv Regional Oncological Dispensary
-
Kyiv、ウクライナ、03115
- State Institution Institute of Urology NAMS of Ukraine based on Kyiv City Clinical Oncology Center
-
Kyiv、ウクライナ、03022
- State Nonprofit Enterprise National Cancer Institute
-
Lviv、ウクライナ、79010
- Communal Noncommercial Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital'
-
Vinnitsa、ウクライナ、21029
- Podilskiy Regional Center of Oncology
-
Zhytomyr、ウクライナ、10002
- Municipal non-profit enterprise Zhytomyr Regional Oncology Dispensary of Zhytomyr Regional Council
-
-
-
-
-
Delft、オランダ、2625 AD
- Reinier de Graaf Gasthuis
-
Hilversum、オランダ、1213XZ
- Tergooiziekenhuizen
-
Nijmegen、オランダ、6532 SZ
- Canisius-Wilhelminaziekenhuis
-
Tilburg、オランダ、5022 GC
- Elisabeth-TweeSteden Ziekenhuis
-
-
-
-
-
Birtinya、オーストラリア、4575
- Sunshine Coast University Hospital
-
Darlinghurst、オーストラリア、2010
- St Vincent s Hospital Sydney
-
Herston、オーストラリア、4029
- Cancer Care Services Clinical Research Unit
-
Hobart、オーストラリア、7000
- Royal Hobart Hospital
-
Kurralta Park、オーストラリア、5037
- Icon Cancer Centre Kurralta Park
-
Liverpool、オーストラリア、2170
- Liverpool Hospital
-
Melbourne、オーストラリア、3000
- Peter MacCallum Cancer Centre
-
Murdoch、オーストラリア、6150
- Fiona Stanley Hospital
-
North Ryde、オーストラリア、2109
- Macquarie University Hospital
-
South Brisbane、オーストラリア、4101
- ICON Cancer Care
-
Subiaco、オーストラリア、6008
- St John of God Subiaco Hospital
-
-
-
-
Alberta
-
Calgary、Alberta、カナダ、T2V 1P9
- Prostate Cancer Centre
-
Edmonton、Alberta、カナダ、T6G 1Z2
- Cross Cancer Institute
-
-
British Columbia
-
Kelowna、British Columbia、カナダ、V1Y 5L3
- British Columbia Cancer Agency(BCCA)-Sindi Ahluwalia Hawkins Centre for the Southern Interior(CSI)
-
Vancouver、British Columbia、カナダ、V5Z 4E6
- British Columbia Cancer Agency BCCA Vancouver Centre
-
Victoria、British Columbia、カナダ、V8R 6V5
- British Columbia Cancer Agency Vancouver Island Centre
-
-
Ontario
-
Hamilton、Ontario、カナダ、L8N 4A6
- McMaster Institute of Urology
-
Kingston、Ontario、カナダ、K7L2V7
- Kingston Health Sciences Centre, Kingston General Health Research Institute
-
Toronto、Ontario、カナダ、M5G2M9
- Princess Margaret Cancer Centre University Health Network
-
Toronto、Ontario、カナダ、M4N 3M5
- Sunnybrook Health Sciences Center
-
-
Quebec
-
Montreal、Quebec、カナダ、H3T 1E2
- McGill University - Jewish General Hospital
-
Montreal、Quebec、カナダ、H2X 0A9
- Centre Hospitalier de l'Universite de Montreal
-
-
-
-
-
Gothenburg、スウェーデン、413 45
- Salgrenska University hospital
-
Malmö、スウェーデン、205 02
- Urologiska Mottagningen
-
Stockholm、スウェーデン、17164
- Karolinska Universitetssjukhuset Solna
-
Stockholm、スウェーデン、11883
- Sodersjukhuset
-
-
-
-
-
A Coruña、スペイン、15006
- Hosp Univ A Coruna
-
Barcelona、スペイン、08025
- Hosp. de La Santa Creu I Sant Pau
-
Barcelona、スペイン、08036
- Hosp Clinic de Barcelona
-
Castellon、スペイン、12004
- Hosp. Gral. Univ. de Castellon
-
Girona、スペイン、17007
- Institut Català D'Oncologia Girona
-
Jerez de la Frontera、スペイン、11407
- Hosp. de Jerez de La Frontera
-
Madrid、スペイン、28041
- Hosp. Univ. 12 de Octubre
-
Madrid、スペイン、28034
- Hosp. Univ. Ramon Y Cajal
-
Madrid、スペイン、28046
- Hosp. Univ. La Paz
-
Madrid、スペイン、28006
- Hosp. Univ. de La Princesa
-
Madrid、スペイン、28660
- Hosp. Univ. Hm Monteprincipe
-
Málaga、スペイン、29010
- Hosp Virgen de La Victoria
-
Sabadell、スペイン、08208
- Corporacio Sanitari Parc Tauli
-
Santander、スペイン、39008
- Hosp. Univ. Marques de Valdecilla
-
Seville、スペイン、41013
- Hosp. Virgen Del Rocio
-
Valencia、スペイン、46010
- Hosp. Clinico Univ. de Valencia
-
-
-
-
-
Bangkok、タイ、10330
- King Chulalongkorn Memorial Hospital
-
Bangkok、タイ、10700
- Siriraj Hospital
-
Bangkok、タイ、10400
- Ramathibodi Hospital
-
-
-
-
-
Brno、チェコ、656 91
- Fakultni nemocnice u sv. Anny v Brne
-
Hradec Králové、チェコ、500 05
- FN Hradec Kralove, Urologicka klinika
-
Liberec、チェコ、460 63
- Krajská nemocnice Liberec
-
Olomouc、チェコ、77900
- Uromedical Center s.r.o.
-
Prague、チェコ、128 00
- Urologicka klinika 1 LF UK a VFN
-
-
-
-
-
Aalborg、デンマーク、9000
- Aalborg University Hospital
-
Copenhagen、デンマーク、2100
- Copenhagen University Hospital
-
Herlev、デンマーク、DK-2730
- Herlev Hospital
-
Næstved、デンマーク、4700
- Næstved Hospital
-
Odense、デンマーク、DK-5000
- Odense Universitetshospital
-
Vejle、デンマーク、DK-7100
- Vejle Hospital
-
-
-
-
-
Adana、トルコ(Türkiye)、01250
- Adana Baskent Yuregir Hospital
-
Ankara、トルコ(Türkiye)、06520
- Memorial Ankara Hastanesi
-
Ankara、トルコ(Türkiye)、06800
- Ankara Bilkent Sehir Hastanesi
-
Ankara、トルコ(Türkiye)、06590
- Ankara University Medical Faculty
-
Ankara、トルコ(Türkiye)、06200
- Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi
-
Ankara、トルコ(Türkiye)、06560
- Gazi Hastanesi
-
Bursa、トルコ(Türkiye)、16310
- Bursa Yuksek lhtisas EAH Medikal Onkoloji Klinigi
-
Edirne、トルコ(Türkiye)、22030
- Trakya University Medical Faculty
-
Istanbul、トルコ(Türkiye)、34147
- Bakirkoy Training and Research Hospital
-
Istanbul、トルコ(Türkiye)、34000
- Istanbul University Istanbul Medical Faculty
-
Istanbul、トルコ(Türkiye)、34098
- Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
-
Istanbul、トルコ(Türkiye)、34722
- T C Saglik Bakanlıgi Goztepe Prof Dr Suleyman Yalcın Sehir Hastanesi
-
Izmir、トルコ(Türkiye)、35530
- Izmir Medical Point Hospital
-
Izmir、トルコ(Türkiye)、35340
- Dokuz Eylul Universitesi Arastirma ve Uygulama Hastanesi
-
Sakarya、トルコ(Türkiye)、54050
- Sakarya Üniversitesi Tıp Fakültesi Hastanesi
-
Samsun、トルコ(Türkiye)、55200
- Medical Park Samsun Hastanesi
-
-
-
-
-
Braunschweig、ドイツ、38126
- Städtisches Klinikum Braunschweig gGmbH - Standort Salzdahlumer
-
Cologne、ドイツ、50937
- Universitaetsklinikum Koelnt
-
Dresden、ドイツ、01307
- Universitätsklinik Carl Gustav Carus, Med. Klinik u. Poliklinik I
-
Duisburg、ドイツ、47169
- Urologicum Duisburg
-
Hanover、ドイツ、30625
- Medizinische Hochschule Hannover
-
München、ドイツ、81675
- Klinikum rechts der Isar - III. Med. Klinik und Poliklinik
-
Münster、ドイツ、48149
- Universitaetsklinikum Muenster
-
Nürtingen、ドイツ、72622
- Studienpraxis Urologie Drs. Feyerabend
-
-
-
-
-
Auckland、ニュージーランド、1023
- Auckland City Hospital
-
Christchurch、ニュージーランド、8013
- Canterbury Urology Research Trust
-
Dunedin Central、ニュージーランド、9016
- Dunedin Hospital
-
Tauranga、ニュージーランド、3112
- Tauranga Hospital
-
-
-
-
-
Budapest、ハンガリー、1204
- Jahn Ferenc Del-pesti Korhaz es Rendelointezet
-
Debrecen、ハンガリー、4032
- Debreceni Egyetem
-
Gyula、ハンガリー、5700
- Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz
-
Győr、ハンガリー、9024
- Petz Aladar Megyei Oktato Korhaz
-
Miskolc、ハンガリー、3526
- Borsod Abauj Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktato Korhaz
-
Szeged、ハンガリー、6720
- Szegedi Tudomanyegyetem
-
Tatabánya、ハンガリー、2800
- Szent Borbala Hospital Tatabanya
-
-
-
-
-
Angers、フランス、49933
- Institut de Cancerologie de l Ouest ICO
-
Avignon、フランス、84918
- Institut Sainte Catherine
-
Besançon、フランス、25030
- CHRU De Besancon
-
Bordeaux、フランス、33000
- Institut Bergonie
-
Clermont-Ferrand、フランス、63011
- Centre Jean Perrin
-
Dijon、フランス、21000
- Centre Georges Francois Leclerc
-
Lille、フランス、59000
- Centre Oscar Lambret
-
Lyon、フランス、69008
- Hopital Prive Jean Mermoz
-
Lyon、フランス、69008
- Centre Leon Berard
-
Montpellier、フランス、34298
- Institut Regional du Cancer de Montpellier Val d'Aurelle
-
Nancy、フランス、54100
- Polyclinique de Gentilly
-
Poitiers、フランス、86021
- CHU De Poitiers
-
Quimper、フランス、29000
- Centre Hopitalier Inter-Communal De Cornouaille
-
Saint-Mandé、フランス、94163
- HIA Begin
-
Saint-Priest-en-Jarez、フランス、42271
- Institut de Cancérologie de Loire
-
Strasbourg、フランス、67000
- Clinique Sainte Anne
-
Suresnes、フランス、32151
- Hopital Foch
-
Tours、フランス、37044
- CHRU de Tours
-
-
-
-
-
Barretos、ブラジル、14784-400
- Fundacao Pio XII
-
Belo Horizonte、ブラジル、30110-022
- Cetus Oncologia
-
Belo Horizonte、ブラジル、30130-090
- PERSONAL Oncologia de Precisao e Personalizada
-
Curitiba、ブラジル、80810 050
- CIONC Centro Integrado de Oncologia de Curitiba
-
Florianópolis、ブラジル、88020 210
- Grupo ELORA Centro de Pesquisa e Ensino em Saude de Santa Catarina
-
Fortaleza、ブラジル、60 810180
- Pronutrir
-
Goiânia、ブラジル、74605-070
- Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
-
Ipatinga、ブラジル、35162 189
- Fundacao Sao Francisco Xavier
-
Joinville、ブラジル、89201-260
- Instituto Joinvilense de Hematologia e Oncologia Ltda Centro de Hematologia e Oncologia
-
Natal、ブラジル、59075-740
- Liga Norte Riograndense Contra O Cancer
-
Pelotas、ブラジル、96020 080
- UPCO Unidade de Pesquisa Clinica em Oncologia
-
Porto Alegre、ブラジル、90020-090
- Irmandade Santa Casa de Misericordia de Porto Alegre
-
Porto Alegre、ブラジル、90160-093
- Hospital Ernesto Dornelles
-
Recife、ブラジル、CEP: 50070
- MultiHemo Servicos Medicos S.A
-
Rio de Janeiro、ブラジル、20551-030
- Universidade do Estado do Rio de Janeiro - UERJ
-
Rio de Janeiro、ブラジル、22250 905
- Oncoclinicas Rio de Janeiro S A
-
Rio de Janeiro、ブラジル、20230-130
- Ministerio da Saude Instituto Nacional do Cancer
-
Rio de Janeiro、ブラジル、22775 001
- Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
-
Salvador、ブラジル、40170 110
- Nucleo de Oncologia da Bahia
-
Salvador、ブラジル、41253 190
- Hospital Sao Rafael
-
Santo André、ブラジル、09060 870
- Fundacao do ABC Centro Universitario FMABC
-
Sorocaba、ブラジル、18030-005
- IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado
-
São Paulo、ブラジル、04014-002
- Núcleo de Pesquisa São Camilo
-
São Paulo、ブラジル、01236-030
- Instituto de Ensino e Pesquisa São Lucas
-
São Paulo、ブラジル、01221 020
- Instituto do Cancer Arnaldo Vieira de Carvalho
-
São Paulo、ブラジル、04039-004
- Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE
-
São Paulo、ブラジル、01246 000
- Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
-
São Paulo、ブラジル、01221-020
- Irmandade Santa Casa de Misericordia de Sao Paulo
-
São Paulo、ブラジル、01421-000
- Hospital Alemao Oswaldo Cruz
-
São Paulo、ブラジル、01323 900
- Real e Benemerita Associacao Portuguesa de Beneficencia
-
Uberlândia、ブラジル、38408-150
- Centro Oncológico do Triângulo
-
-
-
-
-
Burgas、ブルガリア、8001
- MHAT Deva Maria
-
Pleven、ブルガリア、5800
- UMHAT Dr Georgi Stranski EAD 1
-
Plovdiv、ブルガリア、4004
- Complex Oncology Center - Plovdiv EOOD
-
Sofia、ブルガリア、1756
- Specialized Hospital for Active Treatment in Oncology
-
Sofia、ブルガリア、1797
- UMHAT Sofia Med
-
Sofia、ブルガリア、1330
- Multifunctional Hospital for Active Treatment for Women Health Nadezhda
-
Vratsa、ブルガリア、3001
- Comprehensive Cancer Center
-
-
-
-
-
Hato Rey、プエルトリコ、00917
- Puerto Rico Medical Research Center
-
-
-
-
-
Babruysk、ベラルーシ、213825
- Bobruisk Interregional Oncology Dispensary
-
Brest、ベラルーシ、224027
- Brest Regional Oncology Dispensary
-
Grodno、ベラルーシ、230017
- Grodno University Hospital
-
Homyel、ベラルーシ、246012
- Gomel Regional Clinical Oncology Dispensary
-
Lesnoy、ベラルーシ、223040
- N N Alexandrov National Cancer Centre of Belarus
-
Minsk、ベラルーシ、220013
- Minsk city Clinical Oncological Dispensary
-
Mogilev、ベラルーシ、212018
- Mogilev Regional Oncology Dispensary
-
Vitebsk、ベラルーシ、210603
- Vitebsk Regional Clinical Oncology Dispensary
-
-
-
-
-
Antwerp、ベルギー、2020
- ZNA Middelheim
-
Antwerp、ベルギー、2610
- ZAS Augustinus
-
Charleroi、ベルギー、6060
- Grand Hopital De Charleroi Site Les Viviers
-
Haine-St-Paul、ベルギー、7100
- Jolimont
-
Liège、ベルギー、4000
- CHC MontLegia
-
Namur、ベルギー、5000
- CHU UCL Namur - Site Sainte Elisabeth
-
Ottignies、ベルギー、1340
- Clinique St Pierre
-
Roeselare、ベルギー、8800
- Algemeen Ziekenhuis Delta
-
-
-
-
-
Almada、ポルトガル、2805-607
- Uls Almada Seixal - Hosp. Garcia de Orta
-
Coimbra、ポルトガル、3000075
- Instituto Português de Oncologia Francisco Gentil - Centro Regional de Oncologia de Coimbra, S.A.
-
Lisbon、ポルトガル、1400-038
- Fund. Champalimaud
-
Lisbon、ポルトガル、1649 035
- Uls Santa Maria - Hosp. Santa Maria
-
-
-
-
-
Bydgoszcz、ポーランド、85 048
- IN VIVO Sp. z o.o
-
Bydgoszcz、ポーランド、85 094
- Szpital Uniwersytecki NR 1 IM Dr Antoniego Jurasza
-
Bydgoszcz、ポーランド、85 796
- Centrum Onkologii im Prof F Lukaszczyka
-
Gdynia、ポーランド、81 519
- Szpitale Pomorskie Sp z o o
-
Konin、ポーランド、62-500
- Przychodnia Lekarska KOMED Roman Karaszewski
-
Krakow、ポーランド、30 539
- Klinika MedTrials
-
Lodz、ポーランド、93-509
- Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi
-
Lublin、ポーランド、20-223
- Medisport
-
Siedlce、ポーランド、08-110
- Urologica Praktyka Lekarska Adam Marcheluk
-
Warsaw、ポーランド、04 073
- Szpital Grochowski Im Dr Med Rafala Masztaka Sp Z O O
-
Wroclaw、ポーランド、53-329
- Specjalistyczna przychodnia lekarska POLIMED
-
-
-
-
-
George Town、マレーシア、10990
- Hospital Pulau Pinang
-
Johor Bahru、マレーシア、81100
- Hospital Sultan Ismail
-
Kuala Lumpur、マレーシア、50586
- Hospital Kuala Lumpur
-
Kuala Lumpur、マレーシア、59100
- University Malaya Medical Centre
-
Kuching、マレーシア、93586
- Sarawak General Hospital
-
Putrajaya、マレーシア、62250
- Institut Kanser Negara Clinical Research Center
-
-
-
-
-
Durango、メキシコ、34000
- Consultorio de Especialidad en Urologia Privado
-
León、メキシコ、37000
- Consultorio Privado
-
Mexico City、メキシコ、3720
- Centro de Investigacion Clínica Gramel S.C.1
-
Monterrey、メキシコ、64710
- i Can Oncology Center
-
Monterrey、メキシコ、64710
- Avix Investigacion Clinica S C
-
Naucalpan、メキシコ、53100
- Oncologia Integral Satelite
-
Oaxaca City、メキシコ、68020
- Centro de Investigacion Clinica de Oaxaca
-
Zapopan、メキシコ、45040
- Consultorio Privado 1
-
-
-
-
-
Barnaul、ロシア、656045
- Altai Regional Oncology Dispensary
-
Chelyabinsk、ロシア、454087
- Chelyabinsk Regional Clinical Center Of Oncology And Nuclear Medicine
-
Ivanovo、ロシア、153040
- Ivanovo Regional Oncology Dispensary
-
Moscow、ロシア、125130
- Moscow City Clinical Hospital # 62
-
Moscow、ロシア、125284
- Hertzen Oncology Research Institute
-
Nizhny Novgorod、ロシア、603001
- Privolzhsky District Medical Centre
-
Omsk、ロシア、644013
- Clinical Oncology Dispensary
-
Pyatigorsk、ロシア、357500
- LLC Novaya Clinica
-
Pyatigorsk、ロシア、357502
- Pyatigorsk Interdistrict Oncology Dispensary
-
Saint Petersburg、ロシア、196603
- Private Medical Institution Euromedservice
-
Saint Petersburg、ロシア、191104
- Leningrad Regional Oncology Dispensary
-
Saransk、ロシア、430032
- Republican Oncology Dispensary
-
Tomsk、ロシア、634050
- Tomsk Cancer Research Institute
-
Tyumen、ロシア、625041
- Multifunctional clinical medical center 'Medical city'
-
Ufa、ロシア、450083
- Bashkir State Medical University
-
-
-
-
-
Beijing、中国、100142
- Beijing Cancer Hospital
-
Beijing、中国、100730
- Beijing Hospital
-
Beijing、中国、100034
- Peking University First Hospital
-
Beijing、中国、100021
- Cancer Hospital Chinese Academy of Medical Sciences
-
Beijing、中国、100191
- Beijing University Third Hospital
-
Beijing、中国、100050
- Beijing Friendship Hospital Capital Medical University
-
Chengdu、中国、610041
- West China Hospital of Sichuan University
-
Chengdu、中国、610083
- Western Theater General Hospital of the Chinese People's Liberation Army
-
Chengdu、中国、610072
- Sichuan Provincial Peoples Hospital
-
Chongqing、中国、400030
- Chongqing University Cancer Hospital
-
Chongqing、中国、400038
- Southwest Hospital, The Third Military Medical University
-
Guangzhou、中国、510180
- Guangzhou First Municipal People's Hospital
-
Guangzhou、中国、510289
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
-
Guangzhou、中国、430030
- Sun Yat Sen University Cancer Center
-
Hangzhou、中国、310014
- Zhejiang Provincial People's Hospital
-
Nanchang、中国、330006
- The First Affiliated Hospital of NanChang University
-
Nanjing、中国、210008
- Nanjing Drum Tower Hospital
-
Nanjing、中国、210000
- Jiangsu Province Cancer Hospital
-
Ningbo、中国、315010
- The First Affiliated Hospital of Ningbo University
-
Shanghai、中国、200032
- Fudan University Shanghai Cancer Center
-
Shanghai、中国、200040
- Huashan Hospital Fudan University
-
Shanghai、中国、200240
- The Fifth People's Hospital of Shanghai, Fudan University
-
Shanghai、中国、200127
- Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University
-
Shanghai、中国、200400
- Huadong Hospital Affiliated to Fudan University
-
Shenyang、中国、110004
- Shengjing Hospital Of China Medical University
-
Suzhou、中国、215006
- The First Affliated Hospital of Soochow University
-
Suzhou、中国、200233
- Second Affiliated Hospital of Soochow University
-
Wenzhou、中国、325000
- The First Affiliated Hospital of Wenzhou Medical University
-
Wuhan、中国、430030
- TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology
-
Xi'an、中国、710061
- The First Affiliated Hospital of Xian Jiaotong University
-
-
-
-
-
Cape Town、南アフリカ、7700
- CancerCare Rondebosch
-
Pretoria、南アフリカ、0001
- Steve Biko Academic Hospital
-
Vosloorus、南アフリカ、1475
- East Rand Urology Research Unit
-
-
-
-
-
Kaohsiung City、台湾、83301
- Kaohsiung Chang Gung Memorial Hospital
-
Kaohsiung City、台湾、807
- Kaohsiung Medical University Chung Ho Memorial Hospital
-
Taichung、台湾、40447
- China Medical University Hospital
-
Taichung、台湾、40705
- Taichung Veterans General Hospital
-
Taichung、台湾、435
- Tungs' Taichung MetroHarbor Hospital
-
Taipei、台湾、10002
- National Taiwan University Hospital
-
Taipei、台湾、11217
- Taipei Veterans General Hospital
-
Taoyuan、台湾、333
- Chang-Gung Memorial Hospital, LinKou Branch
-
-
-
-
-
Busan、韓国、49241
- Pusan National University Hospital
-
Daegu、韓国、41404
- Kyungpook National University Chilgok Hospital
-
Daegu、韓国、42601
- Keimyung University Dongsan Hospital
-
Daejeon、韓国、35015
- Chungnam National University Hospital
-
Gwangju、韓国、61469
- Chonnam National University Hospital
-
Gyeonggi-do、韓国、10408
- National Cancer Center
-
Seongnam-si、韓国、13620
- Seoul National University Bundang Hospital
-
Seoul、韓国、03080
- Seoul National University Hospital
-
Seoul、韓国、05505
- Asan Medical Center
-
Seoul、韓国、03722
- Severance Hospital Yonsei University Health System
-
Seoul、韓国、06351
- Samsung Medical Center
-
Seoul、韓国、06591
- The Catholic University of Korea Seoul St Mary s Hospital
-
Seoul、韓国、06273
- Gangnam Severance Hospital, Yonsei University Health System
-
Suwon、韓国、16499
- Ajou University Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion criteria:
- Pathological diagnosis of prostate adenocarcinoma
- Must have appropriate deleterious homologous recombination repair (HRR) gene alteration
- Metastatic disease as documented by conventional imaging with computed tomography (CT) or magnetic resonance imaging (MRI) (for soft tissue lesions) or 99mTc bone scan (for bone lesions). Participants with a single bone lesion on Technetium-99m (99mTc) bone scan with no other non-nodal metastatic disease must have confirmation of bone metastasis by CT or MRI. Participants with lymph node-only disease are not eligible
- Androgen deprivation therapy (either medical or surgical castration) must have been started >=14 days prior to randomization and participants be willing to continue androgen deprivation therapy (ADT) through the treatment phase
- Other allowed prior therapy for metastatic castration-sensitive prostate cancer (mCSPC): (a) maximum of 1 course of radiation and 1 surgical intervention for symptomatic control of prostate cancer (example, uncontrolled pain, impending spinal cord compression or obstructive symptoms). Participants with radiation or surgical interventions to all known sites of metastatic disease will be excluded from trial participation. Radiation must be completed prior to randomization (b) Up to a maximum of 6 months of ADT prior to randomization; (c) Up to a maximum of 45 days of abiraterone acetate + prednisone (AA-P) prior to randomization (d) Up to a maximum of 2 weeks of ketoconazole for prostate cancer prior to randomization
Exclusion criteria:
- Prior treatment with a poly (adenosine diphosphate-ribose) polymerase inhibitor (PARP inhibitor)
- History of adrenal dysfunction
- Long-term use of systemically administered corticosteroids (greater than [>] 5 milligrams [mg] of prednisone or the equivalent) during the study is not allowed. Short-term use (<=4 weeks, including taper) and locally administered steroids (for example, inhaled, topical, ophthalmic, and intra-articular) are allowed, if clinically indicated
- History or current diagnosis of myelodysplastic syndrome (MDS)/ acute myeloid leukemia (AML)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:トリプル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Niraparib with Abiraterone Acetate plus Prednisone (AAP)
Participants will receive the following in each 28-day treatment cycle: niraparib 200 milligrams (mg) + abiraterone acetate (AA) 1000 mg fixed dose combination (FDC) along with placebo for AA and prednisone 5 mg once daily. |
Participants will receive a FDC of Niraparib 200 mg + AA 1000 mg once daily. Participants will receive prednisone 5 mg once daily. Participants will receive matching placebo for AA once daily. |
|
アクティブコンパレータ:Placebo for Niraparib + AA FDC plus AA and prednisone (AAP)
Participants will receive the following in each 28-day treatment cycle: matching placebo for Niraparib+AA FDC along with AA 1000 mg and prednisone 5 mg once daily. |
Participants will receive prednisone 5 mg once daily. Participants will receive AA 1000 mg once daily. Participants will receive matching placebo for Niraparib +AA FDC once daily. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Breast Cancer Gene (BRCA) Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
時間枠:From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by computerized tomography (CT) or magnetic resonance imaging (MRI) per response evaluation criteria in solid tumors (RECIST) 1.1; (2) progression of bone lesions observed by bone scan per prostate cancer working group 3 (PCWG3) criteria: bone progression was confirmed by subsequent scan greater than or equal to (>=) 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
HRR Effector Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
時間枠:From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by CT or MRI per RECIST 1.1; (2) progression of bone lesions observed by bone scan per PCWG3 criteria: bone progression was confirmed by subsequent scan >= 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
All HRR: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
時間枠:From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by CT or MRI per RECIST 1.1; (2) progression of bone lesions observed by bone scan per PCWG3 criteria: bone progression was confirmed by subsequent scan >= 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
全生存期間(OS)
時間枠:ランダム化開始日(Day -3からDay 1)から83か月まで
|
ランダム化開始日(Day -3からDay 1)から83か月まで
|
|
|
次の治療までの時間
時間枠:無作為化日(Day -3からDay 1)から83ヶ月まで
|
無作為化日(Day -3からDay 1)から83ヶ月まで
|
|
|
治療関連の重篤な有害事象が発生した参加者の数
時間枠:サイクル1 日1から83ヶ月まで
|
サイクル1 日1から83ヶ月まで
|
|
|
治療関連有害事象の重症度別参加者数
時間枠:サイクル1 デイ1から83ヶ月まで
|
サイクル1 デイ1から83ヶ月まで
|
|
|
BRCA Subgroup: Time to Symptomatic Progression
時間枠:From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
HRR Effector Subgroup: Time to Symptomatic Progression
時間枠:From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
All HRR: Time to Symptomatic Progression
時間枠:From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
協力者と研究者
捜査官
- スタディディレクター:Janssen Research & Development, LLC Clinical Trial、Janssen Research & Development, LLC
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- CR108852
- 2020-002209-25 (EudraCT番号)
- 67652000PCR3002 (その他の識別子:Janssen Research & Development, LLC)
- 2023-506365-64-00 (レジストリ識別子:EUCT number)
- 2023 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
The data sharing policy of Johnson & Johnson Innovative Medicine is available at innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。